February 11, 2013: BME and CIVET NCIIA Grant
The Department of Biomedical Engineering (BME) and the Center for innovative Ventures of Emerging Technologies (CIVET) have been awarded a 2-year, $34,500 grant from the National Collegiate Inventors and Innovators Alliance (NCIIA). The program entitled "Biomedical Engineering E-Teams for Healthcare Innovation" aims to implement a new senior designexperience for Biomedical Engineering (BME) students focused on the integration of BME/medicine with translation of innovation to industry. The NCIIA program, which will commence in September 2013, will dovetail and add value to BME and CIVET's NIH supported R25 program, "Merging Innovation, Translational Medicine, and Entrepreneurship in Biomedical Engineering Senior Design" which commenced in September 2012. Professor Martin Yarmush directs the NCIIA program together with Francois Berthiaume and Susan Engelhardt who serve as co-PIs.

June 13, 2012: Martin Yarmush, professor II in the Department of Biomedical Engineering (BME) at the School of Engineering and the Center for Innovative Ventures of Emerging Technologies (CIVET), Rutgers-New Brunswick, is the principal investigator of an award totaling $216,000. The project is titled Merging Innovation, Translational Medicine, and Entrepreneurship in Biomedical Engineering Senior Design is being supported by the National Institute of Biomedical Imaging and Bioengineering. It will be run through the collaborative efforts of BME, CIVET, the Robert Wood Johnson School of Medicine, and the Rutgers Business School. Learn more about Professor Yarmush here.


September 10, 2012: BME and CIVET Awarded 2nd Department of Education GAANN Grant in 3 years
The Department of Biomedical Engineering (BME) and the Center for innovative Ventures of Emerging Technologies (CIVET) have been awarded a second 3-year $399,798 training grant from the U.S. Department of Education program of Graduate Assistance in Areas of National Need (GAANN). The award entitled, "Graduate Training in Emerging Areas of Human Relevant Microphysiological Systems" will provide 3 full graduate fellowships per year for the next 3 years. The main objectives of the program are: 1) to continue to build a vibrant and sustained graduate training program with strong emphasis on cutting-edge research and research translation, and 2) to ensure that our research thrusts are leading edge and integrative so that we develop a distinct breed of professionals that can capitalize on the latest scientific findings and translate them into technological developments in areas such as microscale engineering of human physiological systems, or "Human-on-a-Chip." In this regard, numerous federal agencies (NIH, NSF, DARPA, EPA, etc.), and industry as a whole, have identified a critical need for improved microfabricated physiologic systems to predict efficacy, safety, and toxicology outcomes for candidate therapeutics, and to serve as enhanced disease model systems for basic and applied research. Professor Martin Yarmush serves as principal investigator of both GAANN Programs.


Sofou Receives Research Scholar Grant from the American Cancer Society: Professor Stavroula Sofou received a 4-year, $720,000 Research Scholar Grant from the American Cancer Society to design and evaluate a targeted liposomal antivascular alpha-particle therapeutic approach for the treatment of cancer. Professor Martin Yarmush serves as a consultant on this project, and the Center for Innovative Ventures of Emerging Technologies (CIVET) will assist the team in translating their work to the industrial and clinical arenas.